Kim K blessing precedes price hikes. Transparency pays in Cali. And did we mention a new super duper PAC?
Welcome to the week in review in prescription drug pricing!
1. Just keeping up with the Kardashians’ drug sales
Kim K pushed a morning sickness pill, got a half mil, and the drugmaker bumped the list price. Oh, come on. — (STAT)
2. Elsewhere in California…
The impact of a new drug pricing transparency law ripples throughout the land. — (Bloomberg)
3. Pfizer thrashed, backtracks
Pfizer backed off of hikes because President Trump tweeted. Yeah, OK. But not exactly a long-term solution. — (NYT)
4. ? ? ?
Donut holes, medicare cliffs, and a shady PhRMA ad buy. — (STAT)
5. Look, ma, a patient-powered super PAC!
Patients revolt! — (NBC)